AzTrials
AzTrials

Dermoid CystNCT06816316

Role of Alcohol in Prevention of Recurrence of the Accidentally Opened Angular Dermoid Cyst

A study testing external angular dermoid cysts surgical removal in people with Dermoid Cyst and Choristomas, run by Beni-Suef University at 3 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose to evaluate the effect of alcohol used in accidentally opened dermoid cyst in prevention of inflammation and recurrence Patient and method: Itt is a comparative interventional study ,performed on 60 patients with external angular dermoid cysts that were accidentally opened during surgical removal , they were… Read more about this study

Who is it for?
Ages 1 year to 12 years
Conditions the study is for
Dermoid Cyst, Choristomas
What is being tested?
external angular dermoid cysts surgical removal
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
3 sitesEgypt
Study dates
1 Jan 2019to 30 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Clinical diagnosis of external angular dermoid cyst.
  • Accidental opening of the dermoid cyst during surgical removal.
  • Age: Patients of any age eligible for surgical intervention.
  • Willingness to provide written informed consent for participation in the study.

Who cannot join

  • Recurrent dermoid cysts (previously treated or excised).
  • Complicated dermoid cysts (e.g., preoperatively ruptured or infected).
  • Patients with contraindications to the use of ethyl alcohol (e.g., known hypersensitivity or allergy).
  • Patients with systemic conditions that may impair wound healing (e.g., uncontrolled diabetes, immunocompromised states).
  • Patients who are pregnant or breastfeeding.
  • Patients unable or unwilling to comply with follow-up visits.

Trial locations and contacts

3 sites in 1 country.

Egypt3 sites
  • Fayoum University Hospital

    Al Fayyum, Faiyum Governorate

  • Beni Suef University

    Banī Suwayf

  • Misr University For Science and Technology

    Giza

Other trials in Egypt

About this study

Purpose to evaluate the effect of alcohol used in accidentally opened dermoid cyst in prevention of inflammation and recurrence Patient and method: Itt is a comparative interventional study ,performed on 60 patients with external angular dermoid cysts that were accidentally opened during surgical removal , they were divided into two groups ,Group (A) includes 30 patients where only saline was used to wash the surgical field while group(B) includes 30 patients where ethyl alcohol 70% was used.

Read the detailed description
  1. Study Design and Rationale: This is a comparative interventional study designed to evaluate the efficacy of 70% ethyl alcohol in preventing inflammation and recurrence in cases of accidentally opened external angular dermoid cysts during surgical removal. The rationale for using 70% ethyl alcohol is based on its antimicrobial and antiseptic properties, which may reduce the risk of postoperative infection and cyst recurrence compared to saline irrigation alone.
  2. Patient Recruitment and Group Allocation: Recruitment Sites: Patients were recruited from outpatient clinics at Beni-Suef University Hospitals, Fayoum University Hospitals, and MUST University Hospital. Recruitment Period: May 2022 to May 2024. Group Allocation: Group A (Control Group): 30 patients treated with saline irrigation. Group B (Intervention Group): 30 patients treated with 70% ethyl alcohol.
  3. Surgical Procedure: Preoperative Preparation: Patients were positioned supine, and the surgical site was sterilized using standard antiseptic protocols. Local or general anesthesia was administered based on patient and surgeon preference. Incision and Dissection: A skin incision was made below the eyebrow, followed by subcutaneous and orbicularis dissection to expose the dermoid cyst. Care was taken to avoid accidental rupture, but if the cyst was opened, the following steps were implemented. Cyst Management: The cyst walls and contents were meticulously removed from the surgical field to minimize residual material. Group A (Saline Group): The surgical field was irrigated with sterile saline solution to remove any remnants. Group B (Alcohol Group): The surgical field was cleaned using a gauze soaked with 70% ethyl alcohol to ensure thorough disinfection. Wound Closure: The wound was closed in layers using absorbable sutures for subcutaneous tissues and non-absorbable sutures or skin adhesive for the skin. A sterile dressing was applied.
  4. Postoperative Care: Medications: Both groups received the same regimen of systemic antibiotics (e.g., amoxicillin-clavulanate) and anti-inflammatory drugs (e.g., ibuprofen) for 5-7 days to prevent infection and inflammation. Follow-Up: Patients were monitored at 1 week, 1 month, 3 months, and 6 months postoperatively. At each visit, the surgical site was assessed for signs of inflammation, infection, or recurrence. Any adverse events or complications were recorded.
  5. Data Collection and Analysis: Data Collected: Demographic data (age, sex). Intraoperative details (cyst size, extent of spillage). Postoperative outcomes (infection, inflammation, recurrence). Statistical Methods: Data were analyzed using SPSS version 24. Quantitative variables (e.g., cyst size) were summarized as mean ± standard deviation. Categorical variables (e.g., recurrence rates) were summarized as frequencies and percentages. Comparisons between groups were performed using: ANOVA with post hoc tests for continuous variables. Chi-square test or Fisher's exact test for categorical variables. Pearson correlation coefficient was used to assess relationships between quantitative variables. A p-value < 0.05 was considered statistically significant.
  6. Technical Considerations: Ethyl Alcohol Concentration: 70% ethyl alcohol was chosen for its optimal balance between antimicrobial efficacy and tissue safety. Saline Irrigation: Sterile saline was used as a control to mimic standard surgical practice. Standardization: All procedures were performed by experienced surgeons to ensure consistency in technique and cyst management.
  7. Ethical and Regulatory Compliance: Informed Consent: Written informed consent was obtained from all participants prior to surgery. Ethical Approval: The study protocol was approved by the Ethics Committee of Beni-Suef University and adhered to the principles of the Helsinki Declaration. Patient Safety: Adverse events were monitored and managed promptly to ensure patient safety.
  8. Limitations: The study is limited by its sample size (n=60), which may affect the generalizability of the results. The follow-up period of 6 months may not be sufficient to capture long-term recurrence rates. Potential variability in surgical technique among different surgeons.
  9. Expected Outcomes:

The study aims to demonstrate that 70% ethyl alcohol is more effective than saline in reducing postoperative inflammation and recurrence in accidentally opened dermoid cysts.

If proven effective, this intervention could be incorporated into standard surgical protocols for dermoid cyst management.

Being tested
external angular dermoid cysts surgical removal
Keywords
dermoid cyst, ethyl alcohol, choristomas, lipogranulomatous inflammatory
Medical subject headings
Dermoid Cyst, Choristoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • external angular dermoid cysts surgical removalProcedure or surgery

    Skin incision was done below the eyebrow, subcutaneous and orbicularis dissection was done to remove the cysts. Upon accidental opening of the cyst then removal of the cyst walls and its contents from the surgical field as much as possible was done.

    At this step, in group (A) only saline was used to wash the surgical field from any remnants. In group (B) the surgical field was cleaned with a gauze soaked with ethyl alcohol 70%. Then closure of the wound in both groups.

Study groups in NCT06816316
Study groupRoleWhat they receive
Group (A)Placebo comparatoronly saline was used to wash the surgical field
Receives: Procedure: external angular dermoid cysts surgical removal
group (B)Active comparatorethyl alcohol 70% was used to wash the surgical field
Receives: Procedure: external angular dermoid cysts surgical removal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. post-operative inflammation

    The primary outcome of post-operative inflammation measures the incidence of clinically significant inflammatory responses at the surgical site following excision of an accidentally opened external angular dermoid cyst. Inflammation is defined as the presence of two or more of the following clinical signs:

    Erythema (redness) extending ≥1 cm from the wound edges.

    Edema (swelling) at or around the surgical site.

    Local warmth compared to adjacent skin.

    Pain or tenderness reported by the patient or elicited during palpation.

    Purulent discharge from the incision site.

    Measured: 6 month

Secondary outcomes (1)
  1. recurrence

    The recurrence outcome measures the number of participants who experience a reappearance of the external angular dermoid cyst at the surgical site within the 6-month follow-up period after surgical removal. Recurrence is defined as the presence of a palpable mass or radiologically confirmed lesion (via ultrasound or MRI) that exhibits characteristics consistent with a dermoid cyst. This outcome is a critical measure of the long-term efficacy of the surgical intervention and the intraoperative cleaning method (saline vs. 70% ethyl alcohol) in preventing residual cyst material from causing regrowth.

    Measured: 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2025
  2. Study start1 Jan 2019
  3. Primary completion31 Dec 2023
  4. Study completion30 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06816316
Sponsor's protocol ID
FMBSUREC/01102024/Saeed
Status last verified
Feb 2025
First submitted
28 Apr 2024
Last updated
24 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing external angular dermoid cysts surgical removal in people with Dermoid Cyst and Choristomas, run by Beni-Suef University at 3 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

post-operative inflammation (time frame: 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in